These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 7191289)

  • 81. Study on neutralization of low molecular weight heparin (LHG) by protamine sulfate and its neutralization characteristics.
    Sugiyama T; Itoh M; Ohtawa M; Natsuga T
    Thromb Res; 1992 Oct; 68(2):119-29. PubMed ID: 1335615
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Antithrombin 3, antifactor Xa and heparin.
    Biggs R; Denson KW; Akman N; Borrett R; Hadden M
    Br J Haematol; 1970 Sep; 19(3):283-305. PubMed ID: 5529547
    [No Abstract]   [Full Text] [Related]  

  • 83. Properties of antithrombin III depleted plasma. I. Effect of heparin.
    Holmer E; Söderström G; Andersson LO
    Thromb Res; 1980 Jan 1-15; 17(1-2):113-24. PubMed ID: 6990545
    [No Abstract]   [Full Text] [Related]  

  • 84. Studies on the neutralizing mechanism of antithrombin activity of heparin by protamine.
    Okajima Y; Kanayama S; Maeda Y; Urano S; Kitani T; Watada M; Nakagawa M; Ijichi H
    Thromb Res; 1981 Oct 1-15; 24(1-2):21-9. PubMed ID: 7330836
    [No Abstract]   [Full Text] [Related]  

  • 85. Assessing heparin neutralization following cardiac surgery: sensitivity of thrombin time-based assays versus protamine titration methods.
    LaDuca FM; Zucker ML; Walker CE
    Perfusion; 1999 May; 14(3):181-7. PubMed ID: 10411247
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Effects of Chitosan Derivative N-[(2-Hydroxy-3-Trimethylammonium)Propyl]Chloride on Anticoagulant Activity of Guinea Pig Plasma.
    Drozd NN; Shagdarova BT; Il'ina AV; Varlamov VP
    Bull Exp Biol Med; 2017 Jul; 163(3):340-343. PubMed ID: 28744652
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Amidolytic antifactor Xa assays in the laboratory evaluation of heparin and low molecular weight fractions.
    Walenga JM; Bara L; Samama MM; Fareed J
    Semin Thromb Hemost; 1985 Apr; 11(2):100-7. PubMed ID: 4035361
    [No Abstract]   [Full Text] [Related]  

  • 88. [Automatization of heparin determination using chronometric evaluation of anti-Xa activity of the AT III-heparin complex].
    Sampol J; Rossi JM; Lejay G
    Ann Biol Clin (Paris); 1984; 42(1):21-3. PubMed ID: 6731952
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Synthetic irreversible inhibitors of coagulation enzymes.
    Shaw E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):33-42. PubMed ID: 6177606
    [No Abstract]   [Full Text] [Related]  

  • 90. Evaluation of an amidolytic test for comparative calibration of HMW- and LMW-heparins.
    Münstedt K; Bleyl H; Róka L
    Thromb Res; 1991 Oct; 64(1):23-31. PubMed ID: 1663665
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Anticoagulant activity of heparin octasaccharide.
    Ototani N; Yosizawa Z
    J Biochem; 1981 Nov; 90(5):1553-6. PubMed ID: 7338523
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Inhibitory effect of polyphloretin phosphate upon platelet aggregation and hemodynamic and respiratory changes caused by thrombin and protamine.
    Swedenborg J
    J Pharmacol Exp Ther; 1974 Jan; 188(1):214-21. PubMed ID: 4809271
    [No Abstract]   [Full Text] [Related]  

  • 93. Automated determination of heparin with chromogenic substrates.
    van Putten J; van de Ruit M; Beunis M; Hemker HC
    Haemostasis; 1984; 14(2):184-94. PubMed ID: 6735276
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Automated spectrophotometric heparin assays. Comparison of methods.
    van Putten J; van de Ruit M; Beunis M; Hemker HC
    Haemostasis; 1984; 14(2):195-204. PubMed ID: 6735277
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Precipitation and Neutralization of Heparin from Different Sources by Protamine Sulfate.
    Hogwood J; Mulloy B; Gray E
    Pharmaceuticals (Basel); 2017 Jul; 10(3):. PubMed ID: 28671597
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The effect of polycations on the inhibitory action of antithrombin III on thrombin in the absence and presence of polyanions.
    Schiele U; Heuck CC
    Thromb Res; 1986 Jul; 43(2):187-93. PubMed ID: 3738858
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Ex vivo activity of heparin is not predictive of blood loss after neutralization by protamine.
    Racanelli A; Fareed J
    Thromb Res; 1992 Jul; 67(2):263-73. PubMed ID: 1332215
    [TBL] [Abstract][Full Text] [Related]  

  • 98. New synthetic heparin mimetics able to inhibit thrombin and factor Xa.
    Petitou M; Duchaussoy P; Driguez PA; Hérault JP; Lormeau JC; Herbert JM
    Bioorg Med Chem Lett; 1999 Apr; 9(8):1155-60. PubMed ID: 10328304
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [New data on heparin (a review)].
    Bychkov SM
    Vopr Med Khim; 1981; 27(6):726-36. PubMed ID: 7039095
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Assay of unfractionated and LMW heparin with chromogenic substrates: twin methods with factor Xa and thrombin.
    Handeland GF; Abildgaard U
    Thromb Res; 1984 Sep; 35(6):627-36. PubMed ID: 6506021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.